← Open Payments lookup

REBECCA DAVIS: Open Payments

NPI 1831507078 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,015 in 47 payments from 13 companies in 2025. Trend: 2023 $1,039 · 2024 $944 · 2025 $1,015

Food & beverage: $1,015
CompanyPaymentsAmount
Amgen Inc.13$263
Vanda Pharmaceuticals Inc.8$242
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$82
ABBVIE INC.4$75
AstraZeneca Pharmaceuticals LP3$64
Lundbeck LLC3$64
Lilly USA, LLC3$64
Otsuka America Pharmaceutical, Inc.2$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$34
Exact Sciences Corporation2$33

Products named: FANAPT, REPATHA, OTEZLA, REXULTI, CAPLYTA, BREZTRI, MOUNJARO, VRAYLAR.

Industry payments across LA — which companies pay providers there.